APA citiranje

Finlay, A., Kaplan, A., Beck, L., Antonova, E., Balp, M., Zazzali, J., . . . Maurer, M. (2017). Omalizumab substantially improves dermatology‐related quality of life in patients with chronic spontaneous urticaria. J Eur Acad Dermatol Venereol.

Citação norma Chicago

Finlay, A.Y., A.P Kaplan, L.A Beck, E.N Antonova, M.‐M Balp, J. Zazzali, S. Khalil, and M. Maurer. "Omalizumab Substantially Improves Dermatology‐related Quality of Life in Patients With Chronic Spontaneous Urticaria." J Eur Acad Dermatol Venereol 2017.

MLA citiranje

Finlay, A.Y., et al. "Omalizumab Substantially Improves Dermatology‐related Quality of Life in Patients With Chronic Spontaneous Urticaria." J Eur Acad Dermatol Venereol 2017.